Skip to content
Open Access
  • Home
  • Collections
    • High Impact Articles
    • Jawi Collection
    • Malay Medicine
    • Forensic
  • Search Options
    • UiTM Open Access
    • Search by UiTM Scopus
    • Advanced Search
    • Search by Category
  • Discovery Service
    • Sources
    • UiTM Journals
    • List UiTM Journal in IR
    • Statistic
  • About
    • Open Access
    • Creative Commons Licenses
    • COKI | Malaysia Open Access
    • User Guide
    • Contact Us
    • Search Tips
    • FAQs
Advanced
  • Search
  • Analysis of quality of life af...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Analysis of quality of life after randomized controlled trial of alpha-1 adrenoceptor antagonist alone and in combination with cyclooxygenase-2 inhibitor in patients who underwent low-dose-rate brachytherapy for prostate cancer

Analysis of quality of life after randomized controlled trial of alpha-1 adrenoceptor antagonist alone and in combination with cyclooxygenase-2 inhibitor in patients who underwent low-dose-rate brachytherapy for prostate cancer

Bibliographic Details
Main Authors: Yasushi Nakai, Nobumichi Tanaka, Isao Asakawa, Kazumasa Torimoto, Makito Miyake, Satoshi Anai, Tomomi Fujii, Masatoshi Hasegawa, Kiyohide Fujimoto
Format: Article
Language:English
Published: Termedia Publishing House 2019-09-01
Series:Journal of Contemporary Brachytherapy
Subjects:
cyclooxygenase-2 inhibitor
low-dose-rate brachytherapy
prostate cancer
quality of life
Online Access:https://www.termedia.pl/Analysis-of-quality-of-life-after-randomized-controlled-trial-of-alpha-1-adrenoceptor-antagonist-alone-and-in-combination-with-cyclooxygenase-2-inhibitor-in-patients-who-underwent-low-dose-rate-brachy,54,37786,1,1.html
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.termedia.pl/Analysis-of-quality-of-life-after-randomized-controlled-trial-of-alpha-1-adrenoceptor-antagonist-alone-and-in-combination-with-cyclooxygenase-2-inhibitor-in-patients-who-underwent-low-dose-rate-brachy,54,37786,1,1.html

Similar Items

  • Comparison of PSA value at last follow-up of patients who underwent low-dose rate brachytherapy and intensity-modulated radiation therapy for prostate cancer
    by: Nobumichi Tanaka, et al.
    Published: (2017-08-01)
  • Periodical assessment of genitourinary and gastrointestinal toxicity in patients who underwent prostate low-dose-rate brachytherapy
    by: Tanaka Nobumichi, et al.
    Published: (2013-01-01)
  • Oncological outcome, complications, lower urinary tract symptoms, and health-related quality of life after low-dose-rate salvage brachytherapy for recurrent prostate cancer following primary radiotherapy: a report of 8 cases
    by: Makito Miyake, et al.
    Published: (2017-07-01)
  • Minimal percentage of dose received by 90% of the urethra (%UD90) is the most significant predictor of PSA bounce in patients who underwent low-dose-rate brachytherapy (LDR-brachytherapy) for prostate cancer
    by: Tanaka Nobumichi, et al.
    Published: (2012-09-01)
  • Assessment of lower urinary symptom flare with overactive bladder symptom score and International Prostate Symptom Score in patients treated with iodine-125 implant brachytherapy: long-term follow-up experience at a single institute
    by: Makito Miyake, et al.
    Published: (2017-08-01)

© 2020 | Services hosted by the Perpustakaan Tun Abdul Razak, | Universiti Teknologi MARA | Disclaimer


Loading...